Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.

Ron Renaud, biotech’s serial CEO, is ready for a new assignment — and maybe another deal?

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. When it comes

October 3, 2024

DeSantis, Johnson raise flags around Covid boosters as FDA maintains that they’re safe and effective

This past week, Sen. Ron Johnson (R-WI) pressed public health officials over concerns that Covid-19 shots from certain lots are associated with a greater risk

January 20, 2024

Trajectory of fear of cancer recurrence levels six to 18 months post-breast cancer diagnosis

Researchers examined the predictors of fear of cancer recurrence (FCR) and its trajectory among breast cancer (BC) patients.

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.